middle.news
Race Oncology Secures $3.22m to Launch HARNESS-1 Lung Cancer Trial
9:07am on Tuesday 9th of December, 2025 AEDT
•
Healthcare
Read Story
Race Oncology Secures $3.22m to Launch HARNESS-1 Lung Cancer Trial
9:07am on Tuesday 9th of December, 2025 AEDT
Key Points
Raised $3.22 million via private placement at a 6% premium
Funding supports HARNESS-1 Phase 1a/b trial of RC220 with Tagrisso
Trial received ethics approval; patient enrolment to start early Q1 2026
CEO and shareholders committed to early option conversions to secure funding
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Racura Oncology (ASX:RAC)
OPEN ARTICLE